{"name":"Advicenne Pharma","slug":"advicenne-pharma","ticker":"","exchange":"","domain":"advicennepharma.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQbGwtcEhMVVE5ZHZscTRJc3VQUFBYVjVmeGcwVTMtQzFmTE91bWM2Q0R0VVVucm1GSFZFS0JCQThWOVBGYUNnWFZxMXlaTjQyLVpiZlRuNHpYNDMxbFlhcDdNblBRaHgzTXpfSGFjSTBFZ1ZpYVhrazVqT2hjYzBPQXhhcXN4UEJaZkVyWkFUZGNjYURmanpzemZlZFpNYWM?oc=5","date":"2026-04-06","type":"pipeline","source":"openPR.com","summary":"Cystinuria Treatment Market to Reach US$ 216.50 Million by 2030 - openPR.com","headline":"Cystinuria Treatment Market to Reach US$ 216.50 Million by 2030","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPV240YnRNdUtrbF9tRFBWWmsydUpock5vRnYyOVlJZzNRcDBham1ISmc5Ulh3T1pUWWYyb0tHWkV3eDA4cEMtaW1vTTdTYVE3ZWxWZlJkTkE2OFNzM2ZBbXFXeFpJSnFxV3dSUFp3VXF3UHFaeGVwVnphV3J4bFl6WGV4eW9mOXRDSnN1ejNhaUU0OXlTYXRGemc0RTRsZ005QzJ6azNLQlJRNWJ5d0JrTzBlUXloQU82?oc=5","date":"2026-01-27","type":"regulatory","source":"The Pharma Letter","summary":"Advicenne gains marketing approval and reimbursement for Sibnayal in UAE - The Pharma Letter","headline":"Advicenne gains marketing approval and reimbursement for Sibnayal in UAE","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxQZndoSmQzWVBDN0oxQWs2OFdvZElnRmFnTlZRcnR6akVIUGhiaXZwOWFsNTFqdkc3SDdlR1RONzlrc3ZyVV9QY21Gd1JvalJKVlExOE5ncTFEVUVtVUQta0JtTWhQRGNvUnJPNnlaMmxzSndKMGdUa3BKcmtoR29ZSnFnYlMyekJyaC1JQlViMlIteXVhdUp0dTlCTWwtMmlCLS1CcTAzbmZmX3BqX29KclBaNFN4RXIyUjRYS2l3dHhvSFFpV3ZRS3c3MmFDVHlQY2tWTkdtNHotRXIyVE1V?oc=5","date":"2023-10-18","type":"deal","source":"Business Wire","summary":"Avanzanite Bioscience Expands Partnership With Advicenne in Additional European Countries - Business Wire","headline":"Avanzanite Bioscience Expands Partnership With Advicenne in Additional European Countries","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwJBVV95cUxOMVhubC1xbFJ3aXhQR3JqZVJUd20wTlNWV1lSVUpTYy14T2tYSUNPdzlDUlNMYU9jNFliRnowQkxQa2J2WHdFUEVsMFRuWXRZUldQb3NFdmx4SjU0N01XbDlLcHh0aWViX3E3ZkdLYTU3TEt4TExUcjE2dTFqVkU3Nk9jNTlpYzhOc1B2NzdyOV9IcWFuNGoxbFVTeHNwLTNTbWZEYmFoZTMwalNZR1ZwNEpTNDhYQkRPaHpaYmdSbjJtYUJXRkVrQm1JVHVqRkVmOVhqa01BZldVdWR6VjIwb0dJeHlyNEtLVEUyOG9WdTRKeE1XWkRDaHRxd1Itb3Fxc2F0V19xaWtHVVE?oc=5","date":"2023-02-28","type":"deal","source":"BioSpace","summary":"Avanzanite Bioscience Partners With Advicenne to Commercialize Sibnayal® For the Treatment of Rare Kidney Disease in Germany, Austria, Switzerland and Greece - BioSpace","headline":"Avanzanite Bioscience Partners With Advicenne to Commercialize Sibnayal® For the Treatment of Rare Kidney Disease in Ger","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTE9ZeG5POFFvQTR1NEMwajVNN2k3Q1V2T3pZcElFMUNfT0F4aTRzZ1JWLS1sUm5UcXljSkhJTFdReFpyMThiQzRWQWVkd0UzYmFTRlVBLTAzeDUyZHlxa04tOXhFRkw5SWlY?oc=5","date":"2022-10-20","type":"pipeline","source":"Wiley Online Library","summary":"Management of epilepsy in older adults: A critical review by the ILAE Task Force on Epilepsy in the elderly - Wiley Online Library","headline":"Management of epilepsy in older adults: A critical review by the ILAE Task Force on Epilepsy in the elderly","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxONHdNQ0tueU9iSzhvdmhKS1VWMzg2ZHcyUU9FVHZjdzVXTTFSWUVkSGhZRzVPNzZFNS1VVVdCcm5UVk95N0dUdnVhU1lreGg2TWZUVWx2TmpTOFo4R3hNOUxmZWFMSm5KR3d3a2pOMXR3YUFscjFMY3J1ZnBTMlUwTmNSaHNUR0Y0cG90ZmJtY2stcVVvcGlZSDhmMlM5UjdlSWNn?oc=5","date":"2021-01-29","type":"trial","source":"clinicalleader.com","summary":"AI And Machine Learning Prepare Pharma For The Data Onslaught - clinicalleader.com","headline":"AI And Machine Learning Prepare Pharma For The Data Onslaught","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxOMUNGN3VGMEQ2RkJEcHZ0U0tjVDBnM2RwdVcyODcwUjh1aHJPalU3aDRVNE5OY1ZjUkFSMDdDMXFzUERRZUprc1MwMDlmOVNCZHJaWEVKa3Z1amlubzlPZ0xFZTVDSExpRV81WmtBeW9zZEtwYkJSTEJ5eXpxMFp1amNpVVk2TEVZZ2Z1V2VKaU03YXN1N1RrNjdMYUNCeWRVVy0zVGQwVEgyaWZzSUNz?oc=5","date":"2019-09-12","type":"pipeline","source":"Contract Pharma","summary":"Advicenne Signs Manufacturing Agreement with Elaiapharm Lundbeck - Contract Pharma","headline":"Advicenne Signs Manufacturing Agreement with Elaiapharm Lundbeck","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxQb0YwZm9ncUNmUHIyeVczNUg3QVlTdkhPWmJad0hhTnZQVThNcmNHUllTdG16bkJreVoyT3BGNGJubXAxWFFRRmdOVWlfdVNVVEgxR3ZwWUdFcHd6ZkZkaGRuYkZRdFBVVFRLZmVFSnpFZUhOcmRIVGtWWjhkSGtrNHlmVWYyNlh1aG1YVU1uVlBKZkFmNUxQdS1EbmdXa1hTcThzdnNibkFkV1RkMEs0SEtBV2JwYWV6S0xlZldB?oc=5","date":"2018-11-09","type":"trial","source":"Northern Kentucky Tribune","summary":"CTI Clinical Trial and Consulting Services wins international Prix Galien MedStartUp award - Northern Kentucky Tribune","headline":"CTI Clinical Trial and Consulting Services wins international Prix Galien MedStartUp award","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5tVUhlX2g4S2hGOEp5REFTWmcwMXdwS2NhZFVEeXRBdEJPQ1JGSTVJNHZkRjZJQ3dNRjBvemVBTlo2ZXNtVjZXQzZiX1VuNHl1eW5aOTBXcDg0MzFxTmow?oc=5","date":"2018-06-06","type":"pipeline","source":"NEJM","summary":"Primary Hyperoxaluria - NEJM","headline":"Primary Hyperoxaluria","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}